Avidity Biosciences, Inc.
RNA
$26.57
-$1.53-5.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.20% | 192.78% | 125.33% | 56.21% | -2.52% |
| Total Receivables | 227.29% | 1,821.00% | 1,228.32% | 804.00% | 122.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 71.43% | 18.14% | 27.76% | -2.90% | -12.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 152.29% | 191.97% | 123.50% | 56.49% | -1.87% |
|
|
|||||
| Total Current Assets | 152.29% | 191.97% | 123.50% | 56.49% | -1.87% |
| Net Property, Plant & Equipment | 9.83% | -7.31% | -0.42% | 1.09% | 10.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 456.38% | 387.17% | 339.36% | -0.69% | -29.80% |
| Total Assets | 148.81% | 186.27% | 120.61% | 54.97% | -1.60% |
|
|
|||||
| Total Accounts Payable | -3.95% | 38.05% | 57.24% | -39.89% | 89.97% |
| Total Accrued Expenses | 62.35% | 60.14% | 37.48% | 18.85% | 1.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.63% | 5.61% | 19.49% | 19.08% | 17.20% |
| Total Finance Division Other Current Liabilities | -26.01% | 898.98% | 600.71% | 416.18% | 462.69% |
| Total Other Current Liabilities | -26.01% | 898.98% | 600.71% | 416.18% | 462.69% |
| Total Current Liabilities | 21.49% | 87.48% | 86.13% | 55.88% | 55.43% |
|
|
|||||
| Total Current Liabilities | 21.49% | 87.48% | 86.13% | 55.88% | 55.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -52.41% | -45.59% | -27.43% | -22.29% | -18.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -7.18% | -- | -- | -- | 3,211.58% |
| Total Liabilities | 8.72% | 146.68% | 144.91% | 118.98% | 110.44% |
|
|
|||||
| Common Stock & APIC | 116.08% | 122.12% | 89.44% | 51.43% | 14.06% |
| Retained Earnings | -56.47% | -54.96% | -55.12% | -55.65% | -59.19% |
| Treasury Stock & Other | 2,221.60% | 478.17% | 83.01% | 69.65% | 104.63% |
| Total Common Equity | 184.56% | 190.53% | 118.36% | 48.66% | -13.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 184.56% | 190.53% | 118.36% | 48.66% | -13.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 184.56% | 190.53% | 118.36% | 48.66% | -13.37% |
|
|
|||||
